Literature DB >> 11165387

Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study.

O Braissant1, H Henry, M Loup, B Eilers, C Bachmann.   

Abstract

Creatine is synthesized from arginine by L-arginine:glycine amidinotransferase (AGAT) and S-adenosyl-L-methionine:N-guanidinoacetate methyltransferase (GAMT) and can be taken up by cells by creatine transporters (CRT). While creatine is mainly synthesized by the liver and the kidney, most of other tissues, including the brain, also express AGAT and GAMT. There is evidence that the permeability of the blood-brain barrier (BBB) for creatine is limited, suggesting that the brain is dependent on its own creatine synthesis. In order to better understand creatine synthesis and transport in the central nervous system (CNS), we studied the regional distribution of cells expressing AGAT, GAMT and the creatine transporter CRT1 in the adult rat brain by non-radioisotopic in situ hybridization. AGAT and GAMT presented an ubiquitous neuronal and glial expression, whereas CRT1 was present in neurons and oligodendrocytes throughout the brain, but not in astrocytes. This indicates that all cells in the CNS can synthesize creatine from arginine. The absence of expression of CRT1 in astrocytes and particularly in those contacting capillary endothelial cells (BBB) reinforces the idea that under normal conditions the creatine used by the brain is synthesized mainly in the CNS. Furthermore, the expression of CRT1 by neurons and oligodendrocytes indicates that creatine trafficking is possible in those brain areas of main creatine consumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165387     DOI: 10.1016/s0169-328x(00)00269-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  48 in total

1.  beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits.

Authors:  Tarja Malm; Michael Ort; Leena Tähtivaara; Niko Jukarainen; Gundars Goldsteins; Jukka Puoliväli; Antti Nurmi; Raimo Pussinen; Toni Ahtoniemi; Taina-Kaisa Miettinen; Katja Kanninen; Suvi Leskinen; Nina Vartiainen; Juha Yrjänheikki; Reino Laatikainen; Marni E Harris-White; Milla Koistinaho; Sally A Frautschy; Jan Bures; Jari Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

2.  Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity.

Authors:  Shih-Kuang S Hong; Brad E Maltz; Lori A Coburn; James C Slaughter; Rupesh Chaturvedi; David A Schwartz; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

3.  The time course of the adaptations of human muscle proteome to bed rest and the underlying mechanisms.

Authors:  Lorenza Brocca; Jessica Cannavino; Luisa Coletto; Gianni Biolo; Marco Sandri; Roberto Bottinelli; Maria Antonietta Pellegrino
Journal:  J Physiol       Date:  2012-07-30       Impact factor: 5.182

4.  Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum.

Authors:  Alexandra I Zugno; Emilene B S Scherer; Patrícia F Schuck; Diogo L Oliveira; Suzana Wofchuk; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2006-04-27       Impact factor: 3.584

5.  FTIR imaging of brain tissue reveals crystalline creatine deposits are an ex vivo marker of localized ischemia during murine cerebral malaria: general implications for disease neurochemistry.

Authors:  Mark J Hackett; Joonsup Lee; Fatima El-Assaad; James A McQuillan; Elizabeth A Carter; Georges E Grau; Nicholas H Hunt; Peter A Lay
Journal:  ACS Chem Neurosci       Date:  2012-09-11       Impact factor: 4.418

6.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.

Authors:  Dae Won Kim; Seong-Il Yeo; Hea Jin Ryu; Ji-Eun Kim; Hong-Ki Song; Oh-Shin Kwon; Soo Young Choi; Tae-Cheon Kang
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

8.  Arginine supplementation in four patients with X-linked creatine transporter defect.

Authors:  C Fons; A Sempere; A Arias; A López-Sala; P Póo; M Pineda; A Mas; M A Vilaseca; G S Salomons; A Ribes; R Artuch; J Campistol
Journal:  J Inherit Metab Dis       Date:  2008-10-16       Impact factor: 4.982

Review 9.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

10.  Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.

Authors:  Zoe Ireland; Aaron P Russell; Theo Wallimann; David W Walker; Rod Snow
Journal:  BMC Dev Biol       Date:  2009-07-01       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.